Cargando…
Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189185/ https://www.ncbi.nlm.nih.gov/pubmed/30297771 http://dx.doi.org/10.1038/s41416-018-0275-7 |
| _version_ | 1783363311832662016 |
|---|---|
| author | Roseweir, Antonia K. McMillan, Donald C. Edwards, Joanne |
| author_facet | Roseweir, Antonia K. McMillan, Donald C. Edwards, Joanne |
| author_sort | Roseweir, Antonia K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6189185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61891852019-10-09 Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” Roseweir, Antonia K. McMillan, Donald C. Edwards, Joanne Br J Cancer Correspondence Nature Publishing Group UK 2018-10-09 2018-10-02 /pmc/articles/PMC6189185/ /pubmed/30297771 http://dx.doi.org/10.1038/s41416-018-0275-7 Text en © Cancer Research UK 2018 https://creativecommons.org/licenses/by/4.0/This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0). |
| spellingShingle | Correspondence Roseweir, Antonia K. McMillan, Donald C. Edwards, Joanne Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title | Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title_full | Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title_fullStr | Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title_full_unstemmed | Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title_short | Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” |
| title_sort | reply to comment of “erk and p38mapk combine to improve survival in patients with braf mutant colorectal cancer” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189185/ https://www.ncbi.nlm.nih.gov/pubmed/30297771 http://dx.doi.org/10.1038/s41416-018-0275-7 |
| work_keys_str_mv | AT roseweirantoniak replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer AT mcmillandonaldc replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer AT edwardsjoanne replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer |